SOR104 Program
Anti-IL-7R⍺ (IL-7/TSLP)
About the program
  • SOR104 is an anti-IL-7Ra Vorabody that blocks IL-7 and TSLP mediated signalling
  • SOR104 can be dosed orally to reach GI tissue or inhaled to treat pulmonary diseases such as asthma
  • The dual mechanism and local delivery platform offer a next generation approach to treat T cell mediated disease
Programs
Read more